Expensive Rx Drugs Put Spotlight On OTC Opportunity – Economist
This article was originally published in The Tan Sheet
Executive Summary
Over-the-counter drug firms have a promising opportunity to market their products as alternatives to Rx drugs for consumers confronted with coverage gaps in Medicare Part D and private insurance plans, a Princeton University economics and public affairs professor advised industry executives
You may also be interested in...
Pharmacists’ Regard Grows For OTCs As Rx Alternatives, APhA Officer Says
Both pharmacists and consumers are paying increasing attention to the use of some OTCs as a solution to the Medicare Part D "coverage gap," according to Timothy L. Tucker, president-elect of the American Pharmacists Association
Pharmacists’ Regard Grows For OTCs As Rx Alternatives, APhA Officer Says
Both pharmacists and consumers are paying increasing attention to the use of some OTCs as a solution to the Medicare Part D "coverage gap," according to Timothy L. Tucker, president-elect of the American Pharmacists Association
Pharmacists’ Regard Grows For OTCs As Rx Alternatives, APhA Officer Says
Both pharmacists and consumers are paying increasing attention to the use of some OTCs as a solution to the Medicare Part D "coverage gap," according to Timothy L. Tucker, president-elect of the American Pharmacists Association